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Abstract
Background: RNA interference (RNAi) has been one of the most rapidly expanding areas of biological research in
the past decade, revolutionizing the ability to analyze gene function. Thorough validation of siRNA duplexes is
required prior to use in experimental systems, ideally by western blotting to show a reduction in protein levels.
However, in many cases good antibodies are not available, and researchers must rely on RT-qPCR to detect
knockdown of the mRNA species.
Findings: We have observed a phenomenon that gives a disparity between analyzing small interfering RNA (siRNA)
efficacy by western blotting of the protein levels and real-time quantitative PCR (RT-qPCR) measurement of mRNA
levels. Detection of this phenomenon was dependent upon the location of the target amplicon for PCR primers
within the mRNA.
Conclusions: Our data suggests that for certain mRNAs, degradation of the 3’ mRNA fragment resulting from
siRNA mediated cleavage is blocked, leaving an mRNA fragment that can act as a template for cDNA synthesis,
giving rise to false negative results and the rejection of a valid siRNA duplex. We show that this phenomenon may
be avoided by the careful design of RT-qPCR primers for each individual siRNA experiment.
Background
RNA interference (RNAi) was first observed in Caenor-
habditis elegans by Fire, Mello et al. [1], who found that
introduction of double stranded RNA resulted in the
silencing of gene expression. In the past decade RNAi
has been one of the most rapidly expanding areas of
biological research, allowing the development of RNAi
as a therapeutic approach in the treatment of several
disorders, including cancer and autoimmune disorders
[2]. The RNAi pathway has also been utilized in vitro,
enabling the knockdown of genes, and revolutionizing
the ability to analyze gene function. The initial stage of
analysis of gene function is to fully characterize the
extent of siRNA mediated gene knockdown, as in many
cases the gene expression is not completely inhibited.
Knockdown of the mRNA is easily quantified using real-
time quantitative PCR (RT-qPCR), whilst knockdown of
the protein is visualized with SDS-PAGE and western
blotting. Here we report upon a phenomenon which
affects RT-qPCR quantification of gene knockdown, and
which could result in false negative results, and the
rejection of valid siRNA duplexes.
RNAi is initiated by the presence of long dsRNA
molecules in the cell. These are cleaved into small-inter-
fering RNA (siRNA) duplexes, 21-26 nucleotides in
length, by Dicer, a member of the RNase III family of
enzymes [3]. In mammalian cells, 21 nucleotide siRNAs
can be introduced directly into the cell by transfection,
in order to achieve gene silencing [4]. The siRNAs are
incorporated into the RNA-induced silencing complex
(RISC), targeting the complex to complementary mRNA
substrates for degradation [5,6]. Degradation of mRNA
by the RNAi pathway is then initiated by cleavage of the
mRNA within the region complementary to the siRNA
[7]. The fate of mRNA fragments generated by siRNA
directed cleavage is not fully understood, but it is
thought that they enter normal cellular mRNA degrada-
tion pathways [8]. For example, in Drosophila, the 5’
fragment is degraded by the exosome, comprising 3’-5’
exonucleases and the Ski complex, while the 3’ fragment
is degraded by the 5’-3’ exonuclease XRN1 [9].
We have observed a phenomenon which may give rise
to false negative results when assessing siRNA induced
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gene knockdown by quantitative real time-PCR (RT-
qPCR). Since western blotting, the preferred method of
detecting knockdown, cannot always be performed due
to the current lack of antibodies to some genes, we pro-
pose the use of a primer design strategy to minimize
observation of false negative results when using
RT-qPCR to detect knockdown.
Materials and methods
Cell Culture
Human dermal microvascular endothelial cells
(HDMECs) were purchased from Promocell (Heidelberg,
Germany) and were cultured in endothelial cell basal
media (EBM) MV2 growth media (C-22221; Promocell,
Heidelberg, Germany), supplemented with 5% (v/v) fetal
calf serum (FCS) and EGF (5 ng/ml), VEGF (0.5 ng/ml),
FGF-2 (10 ng/ml), long R3 insulin growth factor-1
(20 ng/ml), hydrocortisone (0.2 μg/ml) and ascorbic acid
(1 μg/ml) (supplement pack C-39221; Promocell, Hei-
delberg, Germany).
siRNA transfection
siRNA duplexes were obtained from Qiagen (Crawley,
UK). HDMECs were transfected with siRNA duplexes at
concentrations of 1-10 nM using 0.1% (v/v) Lipofecta-
mine RNAiMAX (Invitrogen, Paisley, UK), according to
the manufacturer’s instructions. Transfection reactions
were performed in serum-free OptiMEM (Invitrogen,
Paisley, UK). Cell media was changed to serum contain-
ing media 4 hours after transfection.
RT-qPCR
Total RNA was extracted from HDMECs using the
RNeasy mini kit (Qiagen, Crawley, UK), 24 and
72 hours post-transfection. DNase treatment was per-
formed using the on-column DNase digestion (Qiagen,
Crawley, UK). One μg total RNA was used for cDNA
synthesis with M-MLV reverse transcriptase and either
random hexamers or oligo(dT) (18T) primers. RT-qPCR
was performed using Power SYBR Green Mastermix
(Applied Biosystems, Warrington, UK). Primers were
designed using the Invitrogen oligoperfect designer web
tool, and were designed to give an amplicon of approxi-
mately 150 base pairs (figure 1A). Primer sequences
were screened using a BLAST search to confirm specifi-
city, and the PCR products run on an agarose gel to
confirm that products of the expected size were
detected. The efficiency of each primer set for RT-qPCR
was determined to be between 95 and 100%. Alterna-
tively pre-designed primers from Qiagen (Crawley, UK)
were purchased. Reactions were analyzed upon an ABI
7000 real-time PCR machine using the following cycle
conditions: 50°C for 10 minutes, 95°C for 10 minutes,
followed by 40 cycles at 95°C for 15 seconds and 60°C
for 1 minute. Results were normalized against b-actin
expression.
Immunoblotting
Protein lysates from HDMECs were prepared in LDS
sample buffer containing 2.5% (v/v) b-mercaptoethanol.
Proteins were resolved by SDS-PAGE on 4-12% NuPage
Figure 1 Relative location of siRNA target sites and primer amplicons. (A) Target mRNA sequence of each PKCε siRNA duplex, and
sequences for each PKCε primer set. (B) Location of primer amplicons (set 1-5) in relation to the sites of siRNA directed cleavage (siRNA 1 and
siRNA 2) of human PKCε mRNA.
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Gels, and transferred onto nitrocellulose membranes
(GE Healthcare, Bucks, UK). Membranes were blocked
with 5% BSA. Antibodies to the C-terminus of PKCε
and to actin were obtained from Millipore (Watford,
UK) and Santa Cruz (Heidelberg, Germany) respectively.
Membranes were washed 6 times with TBS-T, and incu-
bated with peroxidase-conjugated secondary antibodies
(GE Healthcare, Bucks, UK/Sigma, Dorset, UK). Blots
were detected using an enhanced chemiluminescence
(ECL) detection kit (GE Healthcare, Bucks, UK).
Results and Discussion
Validated siRNA duplexes directed to protein kinase
C-epsilon (PKCε) mRNA were used to knockdown PKCε
expression in HDMEC. Two separate duplexes were
used targeting separate regions of the target mRNA
(figure 1A-B). A series of primers were designed to
detect amplicons along the length of the PKCε mRNA
transcript (figure 1B). Successful knockdown of PKCε
was observed using either of the siRNA duplexes as
seen by the reduced levels of protein (figure 2A). Data
obtained from RT-qPCR analysis of mRNA levels fol-
lowing siRNA knockdown, 24 and 72 hours post-trans-
fection, is summarized in figures 2B &2C. In the case
of siRNA duplex 1, all 5 primer sets had been
designed to detect amplicons 3’ to the site of siRNA
directed cleavage. However, only primer sets 1-3 were
actually able to detect the knockdown. Primer sets 5’
of the cleavage site for siRNA duplex 2 detected the
knockdown (sets 1 and 2), as did flanking primers
designed to amplify the region containing the siRNA
target sequence (set 3). However, primers designed to
amplify sequences 3’ of the cleavage site did not detect
the knockdown (sets 4 and 5). There was no difference
observed between data obtained using either oligo(dT)
primers or random hexamers for cDNA synthesis (data
not shown), confirming that this effect was not due to
the cDNA priming method; oligo(dT) primers bind to
the polyA tail of mRNA, while random hexamers bind
to multiple sites along the mRNA molecule. We also
confirmed that all the primer sets produced only a sin-
gle PCR amplicon of expected size by running the pro-
ducts on an agarose gel (figure 2D).
Our data indicates that the location of the PCR ampli-
con could have implications for the validation of siRNA
knockdown. Primers that were used to detect amplicons
close to the 3’ end of the mRNA did not detect the
knockdown, whilst primers used to detect regions closer
to the 5’ end of the mRNA successfully detected the
knockdown. We propose that degradation of the 3’
mRNA fragment resulting from siRNA mediated clea-
vage is blocked, leaving an mRNA fragment that can act
as a template for cDNA synthesis. The cause of this dis-
ruption is unknown, but could be related to the
presence of RNA binding proteins, or due to the sec-
ondary structure of the mRNA. It has previously been
reported that siRNA treatment can result in the accu-
mulation of 3’ mRNA cleavage products within the cell
[10]. The authors suggest that this is due to the satura-
tion of mRNA degradation pathways due to the rapid
rate of the initial cleavage step, performed by the RISC
complex. However, one would expect to see the mRNA
cleavage products degraded within 24-48 hours post-
transfection [11], whereas we were still able to detect
PCR amplicons with primer sets 4 and 5 at 72 hours
post-transfection (figure 2C). In addition, screening of
other classical (PKC-a) and novel (PKC-δ, PKC-h)
members of the PKC family using validated siRNAs and
by designing primers along the length of their mRNA,
did not reveal the same phenomenon (data not shown).
PKC-a mRNA was expressed at five-fold higher levels
than PKC-ε mRNA, whereas PKC-δ and PKC-h mRNA
were expressed at very similar levels to PKC-ε (data not
shown). Taken together, this data suggests that the
observed phenomenon is unlikely to be due to satura-
tion of the mRNA degradation pathways due to PKCε
mRNA being highly expressed.
The fact that this phenomenon was not observed in all
of the genes tested suggests that it is not common to all
siRNA cleaved mRNA. However, the inability of certain
primers to measure siRNA mediated mRNA degradation
by RT-qPCR has been observed for connective tissue
growth factor (CTGF) gene expression in a transformed
human trabecular cell line [12], suggesting that this phe-
nomena could occur for a number of genes. Our data,
using primary human cells, confirms that this phenom-
enon can occur in non-transformed cells and has the
potential to occur during in vivo delivery of siRNA.
Our finding has implications for the design of RT-
qPCR experiments where primers are designed to gener-
ate short amplicons of 100-200 bp, typified by SYBR
green and TaqMan methodology. Based on our observa-
tions we would recommend that, where possible, pri-
mers should ideally be designed to flank the siRNA
target sequence. This approach would be a reliable
method of ensuring that the initial cleavage of the
mRNA could be detected. However, due to the thermo-
dynamic constraints placed on primer design for use in
RT-qPCR experiments, it is not always possible to
design primers that will flank such a specific region of
the mRNA. In this case it would be advisable to design
primers which would detect regions within the 5’ clea-
vage fragment, and couple this with either oligo(dT), or
anchored oligo(dT) cDNA priming. If the siRNA has
successfully cleaved the mRNA within the target region,
then even in the presence of stabilized mRNA frag-
ments, oligo(dT) priming would only result in a trun-
cated cDNA species due to the cessation of cDNA
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Figure 2 Detection of PKCε knockdown by western blotting (WB) and RT-qPCR. HDMECs were treated with two siRNA duplexes to PKCε,
or with a non-silencing control siRNA (N.S siRNA) at either 1 or 10 nM and RNA or protein prepared at 24-72 hours post-transfection. (A) Protein
lysates prepared 48 hours post-transfection were analyzed for PKCε expression by western blotting (WB). Numbers below the blot denote the
relative intensity of each band. The detection of actin expression was performed to monitor protein loading. (B) The amount of PKCε mRNA
transcript at 24 hours post-transfection was analyzed by RT-qPCR using 5 different primer sets (typical Ct values for each primer set in
untransfected cells were as follows: set 1: 25.7, set 2: 26.04, set 3: 25.8, set 4: 25.43, set 5: 25.51). Relative mRNA expression was determined using
b-actin control (n = 3, mean ± S.D.). (C) The amount of PKCε mRNA transcript at 72 hours post-transfection was also assessed by RT-qPCR
(typical Ct values: set 1: 25.82, set 2: 26.01, set 3: 25.92, set 4: 25.51, set 5: 25.64). Relative mRNA expression was determined using b-actin control
(n = 3, mean ± S.D.). (D) Each primer set was tested to confirm a single PCR amplicon, visualized by agarose gel electrophoresis.
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synthesis at the siRNA target site. Regions 5’ to the clea-
vage site would therefore not be amplified in a PCR
reaction.
Conclusions
We report for the first time a clear disparity between
analyzing siRNA efficacy by western blotting of the pro-
tein levels and RT-qPCR measurement of mRNA levels.
Ultimately the best way to confirm successful knock-
down of a target gene by siRNA is to perform a western
blot. However, if this is not possible RT-qPCR can offer
an alternative approach, as well as allowing the extent of
the knockdown to be quantified. Here we show that the
design of primers for RT-qPCR experiments is an
important consideration, as using a primer set targeted
to the wrong region may result in false negative results,
leading to the rejection of a valid siRNA duplex.
Abbreviations
cDNA: complementary DNA; M-MLV: Moloney murine leukemia virus; mRNA:
messenger RNA; PKCε: protein kinase C-epsilon; RNAi: RNA interference;
RT-qPCR: real-time quantitative polymerase chain reaction; siRNA: small
interfering RNA.
Acknowledgements
The authors received funding from the Medical Research Council (MRC),
Biotechnology and Biological Sciences Research Council (BBSRC), North West
Cancer Research Fund (NWCRF) and Cancer Research Wales (CRW).
Author details
1Department of Pharmacology and Therapeutics, School of Biomedical
Sciences, University of Liverpool, Liverpool, L69 3GE, UK. 2NWCRF Institute,
School of Biological Sciences, Bangor University, Bangor, LL57 2UW, UK.
Authors’ contributions
KH performed the majority of the lab work profiling siRNA knockdown of
PKC-ε and western blotting and co-wrote the paper. CW and EAC designed
and tested PCR primers and validated siRNA duplexes. MJC conceived of the
study, participated in its design and coordination and helped to draft the
manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 18 February 2010 Accepted: 3 March 2010
Published: 3 March 2010
References
1. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC: Potent and
specific genetic interference by double-stranded RNA in Caenorhabditis
elegans. Nature 1998, 391:806-811.
2. Kurreck J: RNA interference: from basic research to therapeutic
applications. Angew Chem Int Ed Engl 2009, 48:1378-1398.
3. Bernstein E, Caudy AA, Hammond SM, Hannon GJ: Role for a bidentate
ribonuclease in the initiation step of RNA interference. Nature 2001,
409:363-366.
4. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T: Duplexes
of 21-nucleotide RNAs mediate RNA interference in cultured mammalian
cells. Nature 2001, 411:494-498.
5. Hammond SM, Bernstein E, Beach D, Hannon GJ: An RNA-directed
nuclease mediates post-transcriptional gene silencing in Drosophila
cells. Nature 2000, 404:293-296.
6. Nykanen A, Haley B, Zamore PD: ATP requirements and small interfering
RNA structure in the RNA interference pathway. Cell 2001, 107:309-321.
7. Elbashir SM, Lendeckel W, Tuschl T: RNA interference is mediated by
21- and 22-nucleotide RNAs. Genes Dev 2001, 15:188-200.
8. Valencia-Sanchez MA, Liu JD, Hannon GJ, Parker R: Control of translation
and mRNA degradation by miRNAs and siRNAs. Gene Dev 2006,
20:515-524.
9. Orban TI, Izaurralde E: Decay of mRNAs targeted by RISC requires XRN1,
the Ski complex, and the exosome. RNA 2005, 11:459-469.
10. Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H: Positional effects of
short interfering RNAs targeting the human coagulation trigger Tissue
Factor. Nucleic Acids Res 2002, 30:1757-1766.
11. Hahn P, Schmidt C, Weber M, Kang J, Bielke W: RNA interference: PCR
strategies for the quantification of stable degradation-fragments derived
from siRNA-targeted mRNAs. Biomol Eng 2004, 21:113-117.
12. Shepard AR, Jacobson N, Clark AF: Importance of quantitative PCR primer
location for short interfering RNA efficacy determination. Anal Biochem
2005, 344:287-288.
doi:10.1186/1756-0500-3-53
Cite this article as: Holmes et al.: Detection of siRNA induced mRNA
silencing by RT-qPCR: considerations for experimental design. BMC
Research Notes 2010 3:53.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Holmes et al. BMC Research Notes 2010, 3:53
http://www.biomedcentral.com/1756-0500/3/53
Page 5 of 5
